title: [Postoperative survival in patients with inoperable lung cancer].
abstract: Despite the advances in treatment in the last two decades, the prognosis in lung cancer remains infavourable. Only 20-25% of the patients are suitable for operative treatment. Almost 75% of the patients are inoperable at the time of diagnosis.
  
  
  METHODS
  We present 148 patients, who underwent non-radical operation for the period 01.01.1997 - 31.12.2005 - 129 men (87.16%) and 19 women (12.84%), age range - 29-65 years (53.67 +/- 0.60).
  
  
  RESULTS
  The mean time of survival for the group submitted to radiotherapy is 13.74 months, while for the group without postoperative radiotherapy is 9.31 months. The mean time of survival for the group submitted to chemotherapy is 9.99 months, while for the group without adjuvant chemotherapy is 10.27 months.
  
  
  CONCLUSIONS
  The radiotherapy significantly improves the survival in the patients with inoperable lung cancer, while the chemotherapy don't increase the survival.
authors.forename: A
authors.initials: A
authors.lastname: Uchikov
authors.forename: I
authors.initials: I
authors.lastname: Dimitrov
authors.forename: B
authors.initials: B
authors.lastname: Hadjiev
authors.forename: D
authors.initials: D
authors.lastname: Grigorov
authors.forename: J
authors.initials: J
authors.lastname: Grudeva-Popova
authors.forename: G
authors.initials: G
authors.lastname: Prisadov
authors.forename: E
authors.initials: E
authors.lastname: Uchikova
authors.forename: G
authors.initials: G
authors.lastname: Paskalev
mesh_terms: D000328:Adult; D000368:Aged; D002031:Bulgaria / Q000453:epidemiology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000453:epidemiology* / Q000532:radiotherapy / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000528:radiation effects / Q000601:surgery*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000453:epidemiology* / Q000532:radiotherapy / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D016019:Survival Analysis